Next Science Ltd (NXS) - Total Liabilities

Latest as of June 2025: AU$10.02 Million AUD ≈ $7.09 Million USD

Based on the latest financial reports, Next Science Ltd (NXS) has total liabilities worth AU$10.02 Million AUD (≈ $7.09 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore NXS cash flow metrics to assess how effectively this company generates cash.

Next Science Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Next Science Ltd's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Next Science Ltd to evaluate the company's liquid asset resilience ratio.

Next Science Ltd Competitors by Total Liabilities

The table below lists competitors of Next Science Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
AGUIA RES LTD AD-20 F:5N91	Germany	€933.55K
Mindax Ltd AU:MDX	Australia	AU$8.67 Million
NSC Groupe SA PA:ALNSC	France	€38.26 Million
Seni Jaya Corporation Bhd KLSE:9431	Malaysia	RM74.37 Million
Shanghai Lingyun Industries Development Co Ltd SHG:900957	China	$423.71 Million
Kincora Copper Ltd V:KCC	Canada	CA$733.00K
Wattana Karnpaet Public Company Limited BK:NEW	Thailand	฿110.88 Million
Stadlauer Malzfabrik Aktiengesellschaft VI:STM	Austria	€257.19K

Liability Composition Analysis (2016–2024)

This chart breaks down Next Science Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Next Science Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.38	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-17.98	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Next Science Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Next Science Ltd (2016–2024)

The table below shows the annual total liabilities of Next Science Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$5.77 Million ≈ $4.08 Million	+13.63%
2023-12-31	AU$5.08 Million ≈ $3.59 Million	-22.14%
2022-12-31	AU$6.52 Million ≈ $4.62 Million	+121.78%
2021-12-31	AU$2.94 Million ≈ $2.08 Million	-37.37%
2020-12-31	AU$4.70 Million ≈ $3.32 Million	+40.70%
2019-12-31	AU$3.34 Million ≈ $2.36 Million	+36.73%
2018-12-31	AU$2.44 Million ≈ $1.73 Million	+336.36%
2017-12-31	AU$559.46K ≈ $395.85K	+125.39%
2016-12-31	AU$248.22K ≈ $175.63K	--

About Next Science Ltd

AU:NXS Australia Drug Manufacturers - Specialty & Generic

Market Cap

$30.02 Million

AU$42.43 Million AUD

Market Cap Rank

#23717 Global

#947 in Australia

Share Price

AU$0.15

Change (1 day)

+0.00%

52-Week Range

AU$0.06 - AU$0.16

All Time High

AU$4.60